IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0298732.html
   My bibliography  Save this article

Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis

Author

Listed:
  • Jia Ma
  • Jianyue Xing
  • Yupeng Zhang
  • Guangzhen Liu

Abstract

Background: IgA nephropathy (IgAN) is the most prevalent primary glomerulonephritis worldwide and a leading cause of chronic kidney failure. There are currently no definitive therapeutic regimens to treat or prevent the progression of IgAN. However, biologic agents offer novel therapeutic approaches that target immunological mechanisms to slow or halt disease progression. The objective of this study is to evaluate the efficacy and safety of biologic agents in patients with IgA nephropathy. Methods: We will systematically search PubMed, EMbase, Web of Science, Cochrane Library, and www.clinicaltrials.gov for randomized controlled trials of biologic agents for the treatment of IgA nephropathy. The search period will span from the establishment of each database until October 2023. The quality assessment of included studies will be performed individually using the revised Cochrane risk-of-bias tool for randomized trials (RoB 2), and meta-analysis will be conducted using Revman 5.4.1 software. Conclusions: The results of this study will provide evidence-based medical evidence for the clinical application of biologic agents in patients with IgA nephropathy. Prospero registration number: CRD42023400450.

Suggested Citation

  • Jia Ma & Jianyue Xing & Yupeng Zhang & Guangzhen Liu, 2024. "Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 19(3), pages 1-9, March.
    • Handle: RePEc:plo:pone00:0298732
    DOI: 10.1371/journal.pone.0298732
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0298732
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298732&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0298732?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0298732. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.